Full-Time

Associate Medical Editor

US Students, MD/DO

Amboss

Amboss

1,001-5,000 employees

Evidence-based medical knowledge platform for clinicians

No salary listed

Remote in Germany + 1 more

More locations: Berlin, Germany

Hybrid

Located in Germany or willing to relocate to Germany.

MD

Category
Content & Writing (1)
Required Skills
LLM
RAG

Get referred to Amboss

See people who can refer or advise you

Requirements
  • An MD or DO degree.
  • Excellent written and verbal communication skills in English.
  • High agency, creativity, and problem-solving skills.
  • Curiosity about artificial intelligence tools and willingness to experiment without requiring a deep technical background.
  • Proficiency in finding, selecting, and interpreting clinical literature and medical society guidelines.
  • A didactic mindset.
  • Full-time or near-full-time availability of at least 30 hours per week.
  • Located in Germany or willing to relocate to Germany.
Responsibilities
  • Work closely with medical professionals to plan, develop, write, and review medical content for students, with a strong focus on the US market.
  • Develop ideas to improve and evolve existing content.
  • Integrate user feedback and new evidence-based guidelines to keep content current and relevant to target users.
  • Become proficient in using the content management system that integrates text, images, and videos to create the AMBOSS QBank.
  • Use low-code automation and retrieval-augmented generation tools, with human oversight, to support accurate editorial work.
  • Build intermediate-to-advanced agentic artificial intelligence skills and apply them hands-on to shape new products for the US student market.
Desired Qualifications
  • USMLE or COMLEX experience.
  • Experience with the creation of educational content.
  • Experience using large language model tools or building artificial-intelligence-supported workflows.
  • Digital literacy or technological proficiency, such as basic computer science skills.
  • Familiarity with the AMBOSS platform, preferably as a current or previous AMBOSS user.
  • Knowledge of or curiosity about emerging tools and resources in US medical education.

AMBOSS provides a medical knowledge platform used by students and clinicians. It combines an interactive library and high-yield question bank for students to study and prep for exams with a clinical decision support system for clinicians to guide patient care using evidence-based recommendations. The platform works online: users search and study from the medical library, practice with questions, and access point-of-care guidance and clinical decision support at the bedside or in clinics. AMBOSS differentiates itself through its physician-founded approach, a global team of physicians, scientists, and engineers, and its breadth of content that serves over a million healthcare professionals in 180+ countries, integrating both learning tools and real-time clinical guidance in one platform. The company aims to improve medical knowledge and clinical decision-making worldwide, helping physicians provide better patient care.

Company Size

1,001-5,000

Company Stage

Late Stage VC

Total Funding

$302M

Headquarters

Berlin, Germany

Founded

2012

Get referred to Amboss

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • AMBOSS launched AI Mode Learning in 2026, expanding daily usage beyond exam prep.
  • The March 2025 €240 million round funds international expansion and selective acquisitions.
  • August 2026 updates and global reach support product depth across 180 countries.

What critics are saying

  • OpenAI, Google, and Epic compress medical search into general-purpose copilots by 2027.
  • UpToDate and clinical AI vendors can undercut AMBOSS in hospital purchasing cycles.
  • If AMBOSS loses clinical-care relevance, it reverts to a student-only subscription business.

What makes Amboss unique

  • AMBOSS spans learning, clinical care, and teaching in one medical platform.
  • Its 2026 AI Mode pairs curated guidelines with inline citations and limits.
  • Physician-built content and 22,000+ questions create a trusted workflow moat.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Mental Health Support

Flexible Work Hours

Remote Work Options

Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
deutsche-startups.de
Jul 30th, 2025
Amboss Raises €240M, Valued at €800M

STARTUPLAND is set for November 5 at Cologne's RheinEnergieStadion, featuring talks, pitches, and networking. Key speakers include Sievert Weiss of Amboss, which raised €240 million at an €800 million valuation, and Shikha Ahluwalia from Balderton Capital, focusing on mental health. Sven Lackinger of Sastrify will discuss challenges in scaling. The event includes a pitch stage for young startups and is part of the RISE in STARTUPLAND-Week, turning Cologne into a startup hub.

Burda Principal Investments
May 13th, 2025
AMBOSS: Transforming Healthcare with AI Support

BPI has invested in AMBOSS, a platform evolving from a medical student tool to an AI-supported clinical companion for healthcare professionals. With over 1 million users globally, AMBOSS is expanding in the US and DACH regions. The company operates a hybrid B2C/B2B model, showing strong growth and profitability. AMBOSS is also expanding into new markets and roles, leveraging AI for reliable clinical decision-making. The investment supports AMBOSS's mission to enhance healthcare outcomes.

Handelsblatt
Apr 24th, 2025
Amboss Targets Global Expansion with Funding

Amboss, a medical learning platform, is aiming to become a market leader by raising significant funds, more than most healthtech startups. The new capital will also be used for acquisitions, with a key focus on expanding in the USA.

deutsche-startups.de
Apr 16th, 2025
Amboss secures €240M investment round

In Q1 2025, over €2.5 billion was invested in more than 40 startups. Notable investments include Finn, Amboss, and Solaris. Finn received up to €1 billion from Citi, Jefferies, and Avellinia Capital. Amboss secured €240 million from Kirkbi, M&G Investments, Lightrock, and existing investors, valuing the company at €800 million. Solaris attracted investment from SBI Group and Boerse Stuttgart Group.

deutsche-startups.de
Mar 25th, 2025
Amboss raises €240 million funding

Amboss has raised €240 million in a funding round led by Kirkbi, MG Investments, and Lightrock, with existing investors also participating. The Berlin-based EdTech company is now valued at approximately €800 million. The new capital will be used to expand into international markets and enhance offerings for healthcare professionals.